Valeptic Cr
No structure available
This product's active ingredient could not be matched to a single known compound.
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Valeptic cr 300 EACH TABLET CONTAINS SODIUM VALPROATE 300,0 mg | 300Prolonged release, film coated tablets | 44006744/2.5/0067Approved 23 May 2025 | Registered | Not determined | PIPIL |
| Valeptic cr 500 EACH TABLET CONTAINS SODIUM VALPROATE 500,0 mg | 500Prolonged release, film coated tablets | 44006844/2.5/0068Approved 23 May 2025 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.